| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kintara Therapeutics, Inc. | Chief Scientific Officer | Options (Right to Buy) | 196,790 | 18 Oct 2024 | Direct | ||
| Kintara Therapeutics, Inc. | Chief Scientific Officer | Common Stock | 0 | 18 Oct 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HURA | Kintara Therapeutics, Inc. | 18 Oct 2024 | 1 | $0 | 4 | Chief Scientific Officer | 22 Oct 2024, 21:12 |
| HURA | Kintara Therapeutics, Inc. | 18 Oct 2024 | 0 | $0 | 3 | Chief Scientific Officer | 22 Oct 2024, 20:13 |